Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Gregory Schwartz to Lipoproteins, LDL

This is a "connection" page, showing publications Gregory Schwartz has written about Lipoproteins, LDL.

 
Connection Strength
 
 
 
0.164
 
  1. Do RQ, Nicholls SJ, Schwartz GG. Evolving targets for lipid-modifying therapy. EMBO Mol Med. 2014 Oct; 6(10):1215-30.
    View in: PubMed
    Score: 0.110
  2. Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation. 2004 Sep 14; 110(11):1406-12.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)